Presentation Nuisance Bleeding with Prolonged Dual Antiplatelet Therapy After AMI and Its Impact on Health Status Presenter: A. P. Amin March 26, 2013 REGISTER for free or LOG IN to view this content ACS/AMI Prevention CAD Pharma Clinical Pharma Factoid Up Next Presentation ADAPT-DES One-Year Results: A Large-Scale, Multicenter, Prospective, Observational Study of the Impact of Clopidogrel and Aspirin Hyporesponsiveness on Patient Outcomes Presenter: Gregg W. Stone March 26, 2013 More slides + Presentation Diagnostic Classification of the Instantaneous Wave-Free Ratio Is Equivalent to FFR and Is Not Improved with Adenosine Administration Presenter: Sayan Sen March 27, 2013 Presentation Betrixaban vs. Warfarin in A-fib Patients: Results of a Phase 2, Randomized, Dose-Ranging Study Presenter: Stuart J. Connolly March 28, 2013 We Recommend
Presentation ADAPT-DES One-Year Results: A Large-Scale, Multicenter, Prospective, Observational Study of the Impact of Clopidogrel and Aspirin Hyporesponsiveness on Patient Outcomes Presenter: Gregg W. Stone March 26, 2013
Presentation Diagnostic Classification of the Instantaneous Wave-Free Ratio Is Equivalent to FFR and Is Not Improved with Adenosine Administration Presenter: Sayan Sen March 27, 2013
Presentation Betrixaban vs. Warfarin in A-fib Patients: Results of a Phase 2, Randomized, Dose-Ranging Study Presenter: Stuart J. Connolly March 28, 2013